National Comprehensive Cancer Network

About NCCN

NCCN News

NCCN welcomes the opportunity to work with reporters on all cancer-related topics. NCCN offers members of the media access to scientific and medical experts, news releases, background research, and much more. We can also help connect press with investigators and clinicians who can discuss research, treatment and issues related to cancer through coordination with media contacts at NCCN Member Institutions.

For news, interviews, photo requests or the most current information and resources available, please contact:

Note: NCCN neither reviews nor approves press releases announcing the inclusion of tests, agents, and/or therapies listed within the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®). For any additional commercial use of NCCN Content in promotional and educational materials, NCCN requires a license and review of content.

Newsroom

Press kits, media advisories, and information on upcoming events.

Press Releases

• JNCCN Study Explores if Insurance is Keeping Pace with Trends in Targeted Cancer Therapy  (07/07/2020)
• NCCN: What People with Cancer and their Caregivers Need to Know about CAR T-Cell Therapy  (07/01/2020)
• How to Recognize Side-Effects from Immunotherapy? New NCCN Guidelines for Patients can Help  (06/29/2020)
• The Charitable Foundation “Leukemia Foundation”, supported by the company Janssen Russia, a pharmaceutical product sub-division of Johnson & Johnson LLC, has provided the first Russian translation of the NCCN Guidelines for Patients on treating multiple myeloma  (06/26/2020)

View more >

Health Care Policy News

View more >

NCCN eBulletin Newsletter

July 6, 2020 | Volume 12 Issue 14

• NCCN Flash Updates: NCCN Templates^® Updated for Vulvar Cancer and Uterine Cancer
• Now Accepting Abstracts for Consideration to be Presented During the NCCN 2021 Annual Conference General Poster Session
• Now Available! NCCN Best Practices Insights Focusing on COVID-19
• What People with Cancer and their Caregivers Need to Know about CAR T-Cell Therapy

June 29, 2020 | Volume 12 Issue 135

• NCCN Flash Updates: NCCN Templates^® Updated for Esophageal and Esophagogastric Junction Cancers and NCCN Guidelines with Evidence Blocks™ Updated for Non-Small Cell Lung Cancer
• New Resource Shares Information for Patients and Caregivers on How to Manage Adverse Events from Immune Checkpoint Inhibitors
• 2020-2021 Series Starting! Monthly Oncology Tumor Boards: A Multidisciplinary Approach to Individualized Patient Care
• Recordings Now Available! NCCN Best Practices Webinar Series: Creative Strategies Implemented during COVID-19 that will Impact the Future of Cancer Care

View more >

NCCN in the News

• AJMC: NCCN Patient Guidelines Highlight Side Effects of Immunotherapy, CAR T-Cell Therapy  (07/03/2020)
• The Cancer Letter: NCCN Guidelines for Patients Can Help Patients Recognize Side-Effects of Immunotherapy  (07/02/2020)
• Oncology Nurse Advisor: Functional Status May Predict Outcomes in Hospitalized Patients With Advanced Cancer  (06/30/2020)
• Becker's Hospital Review: Viewpoint: US Cancer Care System 'Failing' the Black Community  (06/30/2020)

View more >

NCCN Member Institutions in the News

• Number of Hospitalizations Can Be Important Clinical Indicator for Head, Neck Cancer Patients  (06/30/2020)
• Yale Cancer Center Study Validates Combination Therapy for Aggressive Endometrial Cancer  (06/29/2020)
• St. Jude Cloud Portal Expands Access to Treasure Trove of Pediatric Solid Tumor Data  (06/26/2020)
• MSK Researchers Find that Common Cancer Treatments Don’t Worsen Coronavirus Infection   (06/24/2020)

View more >